Munira Borhany: Latest Advances in JAK Inhibitors for Myelofibrosis
Munira Borhany, Hematologist/Hemato‐oncologist at Dr. Ziauddin Hospital and Midciti Hospital, shared a post on LinkedIn:
“At the annual Pakistan Society of Haematology (PSH) Conference (Haemcon 2026), I was invited to chair a session on Coagulation Disorders and to deliver a talk on ‘JAK Inhibitors in Myelofibrosis: Recent Updates and Treatment Sequencing.’
My presentation explored:
- Comparative insights into the four FDA-approved JAK inhibitors in myelofibrosis
- Evolving treatment strategies and recent advances
- NCCN guideline recommendations for low- versus high-risk disease
- Practical management of anemia and thrombocytopenia
- Real-world approaches to treatment sequencing
- Insights from our local PMF data, including improvements in anemia and thrombocytopenia
Beyond the scientific discussions, I had the privilege of presenting the annual financial and developmental report in my capacity as the Secretary and Treasurer of the Pakistan Society of Haematology, highlighting the society’s academic initiatives, collaborations, and vision for advancing haematology care and research.
It was inspiring to exchange ideas with colleagues on how personalised therapy and evidence-based sequencing can meaningfully improve outcomes and quality of life for patients living with myelofibrosis.
I am grateful to the organisers, participants, and fellow haematologists for the engaging discussions, shared insights, and ongoing commitment to advancing patient care.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers